Year archive

Pharmala Biotech Holdings Inc. — 2026 filings

All 22 regulatory filings released by Pharmala Biotech Holdings Inc. (MDMA) in 2026, sourced directly from the official regulator.

22 Filings

2026 Period

2026 filings (22)

Filing	Released	Lang
Material change report - English.pdf Regulatory Filings	2026-05-22	English
News release - English.pdf Capital/Financing Update	2026-05-20	English
Other material contracts - English.pdf Regulatory Filings	2026-05-14	English
News release - English.pdf Regulatory Filings	2026-05-13	English
Notice of the meeting and record date (amended) - English.pdf Regulatory Filings	2026-05-12	English
Notice of the meeting and record date - English.pdf Regulatory Filings	2026-05-01	English
News release - English.pdf Regulatory Filings	2026-04-27	English
News release - English.pdf Earnings Release Q2 2026	2026-04-21	English
52-109FV2 - Certification of interim filings - CEO (E).pdf Regulatory Filings	2026-04-21	English
Interim MD&A - English.pdf Management Reports	2026-04-21	English
52-109FV2 - Certification of interim filings - CFO (E).pdf Regulatory Filings Q1 2026	2026-04-21	English
52-109FV2 - Certification of interim filings - CEO (E).pdf Regulatory Filings	2026-04-21	English
Interim financial statements/report – English.pdf Interim / Quarterly Report H1 2026	2026-04-21	English
News release - English.pdf Capital/Financing Update	2026-04-20	English
News release - English.pdf Regulatory Filings	2026-04-20	English
News release - English.pdf Regulatory Filings	2026-03-23	English
News release - English.pdf Regulatory Filings	2026-03-03	English
News release - English.pdf Regulatory Filings	2026-02-26	English
News release - English.pdf Regulatory Filings	2026-02-23	English
Material change report - English.pdf Regulatory Filings	2026-02-12	English
News release - English.pdf Regulatory Filings	2026-02-10	English
News release - English.pdf Regulatory Filings	2026-01-08	English